BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18698083)

  • 41. Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.
    Schellong G; Riepenhausen M
    Klin Padiatr; 2004; 216(6):364-9. PubMed ID: 15565552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
    Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.
    Duberg AS; Nordström M; Törner A; Reichard O; Strauss R; Janzon R; Bäck E; Ekdahl K
    Hepatology; 2005 Mar; 41(3):652-9. PubMed ID: 15723449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The risk of cancer following hospitalization for infection in infancy: a population-based cohort study.
    Paltiel O; Laniado DE; Yanetz R; Deutsch L; Calderon-Margalit R; Harlap S; Friedlander Y
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1964-8. PubMed ID: 17035406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
    Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
    Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
    Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
    Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
    J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
    Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
    Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second primary malignancies in lymphoma patients.
    Takenaka T; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K; Watanabe S
    Jpn J Clin Oncol; 1985 Jun; 15(2):443-9. PubMed ID: 4021122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of HER-2/neu overexpression in non-Hodgkin's lymphoma.
    Lüftner D; Genvresse I; Geppert R; Kaufmann O; Dietel M; Possinger K
    Anticancer Res; 2004; 24(5B):3233-7. PubMed ID: 15510616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method.
    van der Haring IS; Schaapveld MS; Roodenburg JL; de Bock GH
    Int J Oral Maxillofac Surg; 2009 Apr; 38(4):332-8. PubMed ID: 19196493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonbreast second malignancies after treatment of primary breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second neoplasms after treatment of childhood cancer in Slovenia.
    Jazbec J; Ećimović P; Jereb B
    Pediatr Blood Cancer; 2004 Jun; 42(7):574-81. PubMed ID: 15127411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.
    Hershman DL; McBride RB; Eisenberger A; Tsai WY; Grann VR; Jacobson JS
    J Clin Oncol; 2008 Jul; 26(19):3159-65. PubMed ID: 18591554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.
    Scélo G; Boffetta P; Corbex M; Chia KS; Hemminki K; Friis S; Pukkala E; Weiderpass E; McBride ML; Tracey E; Brewster DH; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Brennan P
    Cancer Causes Control; 2007 Apr; 18(3):269-78. PubMed ID: 17237987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
    M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
    Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y
    Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.